Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monohydrate crystalline form of 3-(5-(4-(3-fluoropropyl)-piperazin-1-yl)benzimidazol-2-yl)-1-azaazulen-2-one, preparation, and pharmaceutical composition thereof

Monohydrate crystalline form of 3-(5-(4-(3-fluoropropyl)-piperazin-1-yl)benzimidazol-2-yl)-1-azaazulen-2-one, preparation, and pharmaceutical composition thereof

US Patent 9012459 · Granted Apr 21, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Androgen receptor binding molecule and use thereof2024
Composition for improving the solubility of poorly soluble substances, use there2023
Composition for improving the solubility of poorly soluble substances, use there2023
Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition cont2023
Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition cont2023
Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising t2020
Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis2020
Biomedical composition2016
Biomedical composition2016
Pharmaceutical composition2016
Pharmaceutical composition2016
Pharmaceutical composition2016